Combined refractive platform offers new level of patient customization

Article

The WaveLight Refractive Suite from Alcon is now available to European doctors. The news came during the 2010 European Society of Cataract and Refractive Surgeons (ESCRS) annual meeting in Paris, France.

The WaveLight Refractive Suite from Alcon is now available to European doctors. The news came during the 2010 European Society of Cataract and Refractive Surgeons (ESCRS) annual meeting in Paris, France.

The suite features the new 200 kHz WaveLight FS200 femtosecond laser and the new 500 Hz WaveLight EX500 excimer laser; combined, the two systems form the world's fastest refractive platform.

"The new WaveLight FS200 femtosecond laser allows me to tailor treatments for patient's individual needs through fully customizable corneal cuts, spot size, depth and energy delivery," said Dr Arthur Cummings, Wellington Eye Clinic & UPMC Beacon Hospital in Dublin, Ireland.

The integrated WaveLight Refractive Suite is also equipped with advanced safety features including a 1050 Hz eye tracker on the WaveLight EX500 excimer laser, providing a 2 millisecond latency time and a Beam Control Check that automatically calibrates each applanation cone used with the WaveLight FS200 femtosecond laser. An additional benefit for improved patient flow is WaveNet, an integrated computer network which provides patient data transfer within the Refractive Suite.

"Our new WaveLight Refractive Suite is designed for these two innovative laser technologies to communicate to deliver precise and predictable outcomes, reduce risk for potential errors, improve patient experience and save surgeons valuable time," said Stuart Raetzman, vice president, Global Marketing and area president for the United States. "The added benefits and features offered through the WaveLight FS200 and EX500 lasers are numerous and further demonstrate our commitment to bringing surgeons the most advanced technologies to meet a wide range of patient needs accurately and efficiently."

The CE Mark for the WaveLight FS200 femtosecond and the WaveLight EX500 excimer lasers were complete in the second quarter of 2010. Alcon anticipates the launch for WaveLight FS200 femtosecond laser in the United States later this year and the WaveLight EX500 excimer laser next year.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.